EP PerMed Joint Transnational Call (JTC) 2025

17, Dec 2024

The European Partnership for Personalised Medicine, EP PerMed, supported by the European Union under Horizon Europe, Grant Agreement N° 101137129, has launched its second joint transnational call (JTC2025) for proposals on “Pharmacogenomic strategies for personalised medicine approaches (PGxPM2025)”. In total, 35 funding organisations participate in this call with an available budget of over 36.5 Mio. € (approx.).

EP PerMed funding organisations, listed, have agreed to jointly fund multinational innovative research projects in personalised medicine (PM), which should bring together academic, clinical/public health and private research teams, thus enhancing the competitiveness in Europe in this field.

The call will be implemented in two stages, i.e. a pre- and a full-proposal phase.

Expected timeline of the call

16 December, 2024	Publication of the call
09 January, 2025	JTC2025 information day - Click the link below to register for the event https://www.eppermed.eu/news-events/events/ep-permed-jtc2025-information-day/
04 February, 2025 (23:00, CET)	Deadline to Complete SAMRC Pre-Eligibility Check Form
18 February, 2025 (14:00, CET)	Deadline for pre-proposal submission
Expected around 15 May, 2025	Communication of the results of the pre-proposal assessment and invitation to the full-proposal stage
17 June, 2025 (14:00, CEST)	Deadline for full-proposal submission
Mid/end of August 2025	Rebuttal stage
Expected for October 2025	Communication of the funding decisions to the applicants
End of 2025, beginning of 2026	Expected project start (according to regional/national funding regulations)

Electronic submission website

Electronic proposal submission is mandatory on PT-Outline. Research project consortia who intend to submit a transnational proposal should register as soon as possible, by clicking on “Sign up” and follow further instructions.